Please ensure Javascript is enabled for purposes of website accessibility

Are the Shorts Wrong About MAKO?

By Dave Williamson - Dec 11, 2012 at 6:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

MAKO Surgical is the sixth most short-sold health-care stock on the market.

MAKO Surgical (MAKO.DL) is the surgical-robot company that many thought might become the next Intuitive Surgical (ISRG -0.83%). However, two terrible quarters to start the year hammered shares price and investor confidence.  In this video, Motley Fool health-care analyst David Williamson tells us what the upside for MAKO might be and whether he thinks the short-sellers are right.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

MAKO Surgical Corp. Stock Quote
MAKO Surgical Corp.
MAKO.DL
General Electric Company Stock Quote
General Electric Company
GE
$66.71 (-0.43%) $0.29
Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
ISRG
$207.94 (-0.83%) $-1.73
Hansen Medical, Inc. Stock Quote
Hansen Medical, Inc.
HNSN

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.